Supplemental material
Current Medical Research and Opinion
Volume 38, 2022 - Issue 9
Rheumatology
Development of a claims-based flare algorithm for systemic lupus erythematosus
Iris Goetza Eli Lilly and Company, Bracknell, UKCorrespondence[email protected]
https://orcid.org/0000-0003-0898-9530
https://orcid.org/0000-0003-0898-9530, Casey Choongb Eli Lilly and Company, Indianapolis, IN, USAhttps://orcid.org/0000-0001-6476-784X
https://orcid.org/0000-0001-6476-784X, , David R. Nelsonb Eli Lilly and Company, Indianapolis, IN, USAhttps://orcid.org/0000-0002-3240-0725
https://orcid.org/0000-0002-3240-0725, Julie Birtb Eli Lilly and Company, Indianapolis, IN, USAhttps://orcid.org/0000-0001-6814-7031
https://orcid.org/0000-0001-6814-7031, Virginia Noxonc IBM Watson Health, Cambridge, MA, USAhttps://orcid.org/0000-0002-6411-8652
https://orcid.org/0000-0002-6411-8652, , & Joseph Tkaczc IBM Watson Health, Cambridge, MA, USAhttps://orcid.org/0000-0003-2369-356X
https://orcid.org/0000-0003-2369-356X show all